AxoGen, Inc.

NASDAQ:AXGN

Medical - Devices

Healthcare
$56.95 +0.56%

+$0.25 today

Market cap
$3.40B
Beta
1.12
P/E (TTM)
-73.4
EPS (TTM)
-$0.61
52W Low $9.35High $45.83

Volume 2.11M

Average 1.08M

AXGN Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

AxoGen, Inc.NASDAQ: AXGN

Weighted Avg Shares · Q3 FY2026 · quarter ended Sep 2026

Weighted avg shares growth accelerates

Q3 FY2026 weighted avg shares of 55.16M shares rose 20.2% year over year, ahead of the +14.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 3.4% from the prior quarter. Over 3 fiscal years it compounded at +3.0% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +20.2% holds above the trailing-twelve-month pace of +14.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
55.16M+3.4% QoQ
Last fiscal yearDec 2025
46.05M+4.0% YoY
LTMSep 2026
51.75M+14.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.2%——
1 year+4.0%——
3-year CAGR+3.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
46.05M USD
Year-over-year change
+4.0%
4-year CAGR
+2.8%

Weighted Avg Shares vs competitors

How AXGN compares with its peers on the latest reported figures

  • AXGN's LTM Sep 2026 weighted avg shares of 51.75M shares is the 6th highest of the 7 companies compared; the peer median is 133.34M shares.
  • Its year-over-year change of +14.0% is the 3rd highest of 7, against a peer median of +2.2%.
  • Over three fiscal years its annual growth of +3.0% compares with a peer median of +13.8%.
AXGN Competitors Peer median
Weighted Avg Shares for AXGN and competitors
Company Period LTM YoY 3-year CAGR
HUMAHumacyte, Inc.LTM Mar 2026167.44M +37.1%+15.3%
MDXGMiMedx Group, Inc.LTM Mar 2026148.01M +0.6%+9.4%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026139.57M +1.9%+14.0%
ORGOOrganogenesis Holdings Inc.LTM Mar 2026127.11M -2.8%-0.9%
TELATELA Bio, Inc.LTM Jun 202652.94M +36.3%+42.4%
AXGNAxoGen, Inc.LTM Sep 202651.75M +14.0%+3.0%
BSEMBioStem Technologies, Inc.LTM Jun 202616.91M +2.5%+13.6%
Peer median (excluding AXGN) 133.34M+2.2%+13.8%

Competitors are the stored peer set for AXGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue127.36M138.58M159.01M187.34M225.21M
Cost of Revenue22.93M29.78M37.14M45.36M57.86M
Gross Profit104.43M108.81M121.87M141.98M167.35M
Gross Margin82.0%78.5%76.6%75.8%74.3%
Research & Development24.18M25.63M27.34M27.77M32.89M
Selling, General & Admin105.67M112.89M115.99M117.5M142.32M
Operating Expenses129.84M138.52M143.33M145.26M175.2M
Depreciation & Amortization4.74M4.85M5.55M7.84M8.19M
EBITDA(20.89M)(23.47M)(13.33M)6.08M192K
EBITDA Margin-16.4%-16.9%-8.4%3.2%0.1%
Operating Income(25.42M)(29.71M)(21.46M)(3.29M)(7.85M)
Operating Margin-20.0%-21.4%-13.5%-1.8%-3.5%
Interest Income00000
Interest Expense1.36M624K2.84M8.21M7.7M
Other Income / Expenses(1.57M)759K(254K)(6.68M)(7.85M)
Income Before Tax(26.99M)(28.95M)(21.72M)(9.96M)(15.7M)
Pre-Tax Margin-21.2%-20.9%-13.7%-5.3%-7.0%
Income Tax Expense00000
Net Income(26.99M)(28.95M)(21.72M)(9.96M)(15.7M)
Net Margin-21.2%-20.9%-13.7%-5.3%-7.0%
EPS (Basic)(0.65)(0.69)(0.51)(0.23)(0.34)
EPS (Diluted)(0.65)(0.69)(0.51)(0.23)(0.34)
Weighted Avg Shares41.22M42.08M42.88M44.26M46.05M
Weighted Avg Shares (Diluted)41.22M42.08M42.88M44.26M46.05M

AxoGen, Inc.

NASDAQ:AXGN

Intrinsic Alpha fair value

Locked

Current Price

$56.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.